Clinical Pharmacology & Therapeutics · 2017 · 70 citations · 33 references
PharmacyPharmacologyToxicologyBioavailabilityPharmacogeneticsToxicokineticsDrug DispositionDrug Transporter GeneticsHeart RateHepatic Drug TransportersHepatic TransportersMetabolic Adverse Drug ReactionsOrganic Cation Transporter 1Systemic Exposure AssessmentSystemic Exposure MeasurementTocolytic Pharmacology
Fenoterol is a widely used anti‐asthmatic and tocolytic agent, but high plasma concentrations of fenoterol may lead to severe and even fatal adverse reactions. We studied whether heritable deficiency of the liver organic cation transporter 1 (OCT1), a trait observed in 3% of Europeans and white Americans, affects fenoterol plasma concentrations and toxicity. OCT1 transported fenoterol with high affinity, and OCT1 inhibition in human hepatocytes reduced fenoterol uptake threefold. After administration of 180 µg of fenoterol to 39 healthy individuals, the OCT1‐deficient individuals (zero active OCT1 alleles; n = 5) showed 1.9‐fold greater systemic fenoterol exposure ( P = 4.0 × 10 −5 ) and 1.7‐fold lower volume of distribution ( P = 8.0 × 10 −5 ). Correspondingly, the OCT1‐deficient individuals had a 1.5‐fold stronger increase in heart rate ( P = 0.002), a 3.4‐fold greater increase in blood glucose ( P = 3.0 × 10 −5 ), and significantly lower serum potassium levels. In conclusion, heritable OCT1 deficiency significantly increases plasma concentrations of fenoterol and may be an important factor underlying the excess mortality associated with fenoterol.
33
Heart rate and cardiovascular mortality: The Framingham study
William B. Kannel, Craig Kannel, Ralph S. Paffenbarger et al. · American Heart Journal · 1987 · 1.3K citations
The Use of β-Agonists and the Risk of Death and near Death from Asthma
Walter O. Spitzer, Samy Suissa, Pierre Ernst et al. · New England Journal of Medicine · 1992 · 1.2K citations · Full text
PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY
Julian Crane, A. Flatt, R. Jackson et al. · The Lancet · 1989 · 628 citations